Overview Memantine - Communication Study Status: Completed Trial end date: 2008-12-01 Target enrollment: Participant gender: Summary The study objective is to evaluate the effects of memantine treatment on communication abilities and other cognitive abilities in moderate to severe DAT patients. Phase: Phase 3 Details Lead Sponsor: Merz Pharmaceuticals GmbHTreatments: Memantine